Home
>
US Stocks
>
Minerva Neurosciences Inc
Minerva Neurosciences Inc
NERV

Minerva Neurosciences Inc (NERV)

$1.2631.89%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
1.26
Today Low/High
1.26 / 1.26
52 Week Low/High
$1.54 / $4.12
Market Cap
$76.04M

Company Details

Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson's disease.
Organisation
Minerva Neurosciences Inc
Headquaters
Waltham, Massachusetts, US
Employees
11
Industry
Health Technology
CEO
Remy Luthringer

Discover more

Frequently Asked Questions

What is Minerva Neurosciences Inc (NERV) share price today?

Can Indians buy Minerva Neurosciences Inc (NERV) shares?

How can I buy Minerva Neurosciences Inc (NERV) shares from India?

Can Fractional shares of Minerva Neurosciences Inc (NERV) be purchased?

What are the documents required to start investing in Minerva Neurosciences Inc (NERV) stocks?

We are a SEBI registered investement advisor